SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company: abrdn Life Sciences Investors
Filed: February 25, 2011
Accession Number: 0000921895-11-000366

View Document ↗ View on SEC.gov ↗